EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Implications of intestinal microecology and immune function alterations for immunotherapy outcomes in advanced unresectable lung adenocarcinoma

Shuang He, Jin Tian, Jianhua Zang, Lin Long, Peng Liu, Yexi Zhang, Jun Xiao iD

The Clinical Respiratory Journal · 2024

DOI: 10.1111/crj.13762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2024. Verfasst von Shuang He und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College of Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lung Neoplasms, Adenocarcinoma of Lung, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Key Program of Science and Technology of Traditional Chinese Medicine, Shandong Provincial Youth Program of Science and Technology of Traditional Chinese Medicine, Qingdao Medical and Health Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This investigation aims to explore alterations in intestinal microecology and immune function among patients with advanced, unresectable lung adenocarcinoma undergoing different outcomes from immunotherapy.

Methods

A cohort of 30 patients diagnosed with advanced unresectable lung adenocarcinoma received sintilimab immunotherapy as a monotherapy. Post four treatment cycles, efficacy was assessed, leading to the segregation of patients into two distinct cohorts: those responsive to treatment and those nonresponsive. Analysis involved observing variations in the abundance, distribution, and composition of fecal intestinal microorganisms pretreatment and posttreatment via 16S rRNA gene sequencing.

Results

In this study involving 30 advanced lung adenocarcinoma patients, significant observations were made regarding the impact of immunotherapy on immune function and the gut microbiome composition. Patients were divided into treatment and control groups, revealing that immunotherapy led to a significant increase in CD4+ T cells and a decrease in CD8+ T cells among the treatment‐responsive individuals, indicating an enhanced immune response. Furthermore, an in‐depth analysis of the gut microbiome showed an increase in diversity and abundance of beneficial bacteria such as Faecalibacterium and Subdoligranulum in the treatment group. These findings highlight the dual effect of immunotherapy on modulating immune function and altering gut microbiome diversity, suggesting its potential therapeutic benefits in improving the health status of patients with advanced lung adenocarcinoma.

Conclusion

The structuring of gut flora plays a pivotal role in augmenting the efficacy of anti‐tumor immunotherapy, underscoring the interplay between intestinal microecology and immune response in cancer treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLung NeoplasmsAdenocarcinoma of LungImmunotherapyHumansMaleFemaleMiddle AgedAgedRNA, Ribosomal, 16STreatment Outcome

Stichwörter der Autor:innen

16S rRNA gene sequencingimmunotherapyintestinal microecologylung adenocarcinoma

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • The First Clinical College of Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Oncology Center I Department, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao, China.
  • Department of Radiotherapy for Oncology, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao, China.
  • Rehabilitation Centre of Acupuncture and Massage, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao, China.

ORCID-Profile: Jun Xiao

Förderung

  • Shandong Provincial Key Program of Science and Technology of Traditional Chinese Medicine
  • Shandong Provincial Youth Program of Science and Technology of Traditional Chinese Medicine
  • Qingdao Medical and Health Research Program
  • 2021 Special Fund for Clinical Research of Wu Jieping Medical Foundation
  • 2022-2024 Qingdao Municipal Clinical Key Specialties-Climbing Peak Discipline Program

Zitieren

APA

He, S., Tian, J., Zang, J., Long, L., Liu, P., Zhang, Y., & Xiao, J. (2024). Implications of intestinal microecology and immune function alterations for immunotherapy outcomes in advanced unresectable lung adenocarcinoma. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.13762

Vancouver

He S, Tian J, Zang J, Long L, Liu P, Zhang Y, et al. Implications of intestinal microecology and immune function alterations for immunotherapy outcomes in advanced unresectable lung adenocarcinoma. The Clinical Respiratory Journal. 2024. doi:10.1111/crj.13762

BibTeX
@article{He2024,
  author = {He, Shuang and Tian, Jin and Zang, Jianhua and Long, Lin and Liu, Peng and Zhang, Yexi and Xiao, Jun},
  title = {Implications of intestinal microecology and immune function alterations for immunotherapy outcomes in advanced unresectable lung adenocarcinoma},
  journal = {The Clinical Respiratory Journal},
  year = {2024},
  doi = {10.1111/crj.13762}
}
Kostenlos starten →